LABORATORIOS FARMACEUTICOS ROVI S.../ ES0157261019 /
| 2024-07-01 9:24:23 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 90.6100USD | - | 100 Turnover: 9,061 |
-Bid Size: - | -Ask Size: - | 4.63 bill.USD | - | - |
Assets
|
2022 IFRS in th. EUR |
2023 IFRS in th. EUR |
|||
|---|---|---|---|---|---|
| Property and Equipment | 215,541 | 253,652 | |||
| Intangible Assets | 35,744 | 33,902 | |||
| Long-Term Investments | 2,202 | 591 | |||
| Fixed Assets | 255,630 | 290,553 | |||
| Inventories | 311,944 | 337,968 | |||
| Accounts Receivable | 180,011 | 143,314 | |||
| Cash and Cash Equivalents | 124,945 | 25,322 | |||
| Current Assets | 623,073 | 509,331 | |||
| Total Assets | 878,703 | 799,884 | |||
Liabilities
|
2022 IFRS in th. EUR |
2023 IFRS in th. EUR |
|||
|---|---|---|---|---|---|
| Accounts Payable | 165,776 | 141,895 | |||
| Long-term debt | 59,441 | 52,242 | |||
| Liabilities to Banks | - | - | |||
| Provisions | 677 | 1,515 | |||
| Liabilities | 357,324 | 256,390 | |||
| Share Capital | - | - | |||
| Total Equity | 520,012 | 539,387 | |||
| Minority Interests | 1,367 | 4,107 | |||
| Total liabilities equity | 878,703 | 799,884 | |||
Income Statement
|
2022 IFRS in th. EUR |
2023 IFRS in th. EUR |
|||
|---|---|---|---|---|---|
| Revenues | 817,698 | 829,509 | |||
| Depreciation (total) | 22,871 | 24,331 | |||
| Operating Result | 255,848 | 220,254 | |||
| Interest Income | 921 | 556 | |||
| Income Before Taxes | - | - | |||
| Income Taxes | 58,302 | 50,109 | |||
| Minority Interests Profit | -4 | -36 | |||
| Net Income | 199,669 | 170,335 | |||
Per Share
Cash Flow
|
2022 IFRS in th. EUR |
2023 IFRS in th. EUR |
|||
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 237,602 | 113,247 | |||
| Cash Flow from Investing Activities | -57,154 | -52,028 | |||
| Cash Flow from Financing | -154,538 | -160,842 | |||
| Decrease / Increase in Cash | - | - | |||
| Employees | 1,993 | 2,111 | |||
